Category: Bioscience

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), headquartered in Newark, Delaware, has released three technology “roadmaps” designed to benefit the biopharmaceutical community. These long-range plans focus on manufacturing issues involving: (1) Gene Therapy, (2) Vaccines, and (3) Antibody-Drug Conjugates (ADC) and Bi-specific Antibodies. NIIMBL brought together experts from leading biomanufacturers, equipment makers, suppliers,…

By Dan Metz Special to Delaware Business Times Helen Stimson is the president and CEO of Delaware BioScience Association, one of the host organizations of the 2019 BIO International Convention, which will take place in Philadelphia in June of 2019. Among the Delaware representatives, Dr. Eric Kmiec from Christiana Care has been chosen to chair…

Incyte Corporation announced today that it has been named one of the global biotechnology and pharmaceutical industry’s top employers by Science magazine, ranking second on the list of only 20 companies recognized in the publication’s annual Top Employer’s Survey. “We are proud to be recognized as the number two top employer in the biopharma industry…

Delaware Innovation Space embraces smaller startups

By Dan Linehan  Special to Delaware Business Times Like the emerging companies it cultivates, the Delaware Innovation Space has a growth timeline of its own. It started in March 2017 as an incubator guiding fledgling companies through their earliest stages. Like an egg incubator that controls heat and humidity to create an optimal environment to…

The steady rise of Prelude Therapeutics

By Dan Linehan Special to Delaware Business Times It’s natural to draw parallels between Kris Vaddi’s time discovering drugs at Incyte, where he spent 14 years, and his latest startup venture, Prelude Therapeutics. But there are many differences. At Incyte, Vaddi joined a thriving public company with hundreds of millions in cash and investments when…

For the past 20 years, Dr. Charlie Wilson has been a faculty member at Delaware State as part of a career that has also included stops at the University of Delaware (1988–94) and AstraZeneca (’94–97). A former wrestler and track athlete for the Hornets, Wilson holds a Ph.D. in Molecular Biology from UD. At Delaware…

For the past 22 years, John Koh has been a professor of Chemistry and Biochemistry at the University of Delaware. Since January 2017, he has been the interim director of UD’s Delaware Biotechnology Institute — after six years as associate director under Kelvin Lee. The Institute is responsible for helping a variety of constituencies obtain…

Things have been moving quickly at ACROBiosystems. But while it’s often said that speed comes at the expense of quality, the work being done by the company is decidedly first-rate and ahead of that done by competitors. “In just a short amount of time, we have gone from a startup to being one of the…

Trevor Brown has no grandiose dreams of solving the nation’s opioid epidemic single-handedly with his company’s drug disposal pouches. Instead, the CEO of DEact Medical Solutions is interested in being part of a broad-based approach to ending the deaths and addiction. As his company moves into its second year of existence, that vision is getting…